Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction—A Prospective Cohort Study

Whereas tenofovir disoproxil fumarate (TDF) can lead to renal adverse events, tenofovir alafenamide (TAF) has a more favorable renal safety profile. However, the impact of replacing TDF with TAF on renal function and liver parameters among HIV/hepatitis B virus (HBV)-coinfected individuals with rena...

Descripción completa

Detalles Bibliográficos
Autores principales: Surial, Bernard, Béguelin, Charles, Chave, Jean-Philippe, Stöckle, Marcel, Boillat-Blanco, Noémie, Doco-Lecompte, Thanh, Bernasconi, Enos, Fehr, Jan, Günthard, Huldrych F., Schmid, Patrick, Walti, Laura N., Furrer, Hansjakob, Rauch, Andri, Wandeler, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495978/
https://www.ncbi.nlm.nih.gov/pubmed/32925387
http://dx.doi.org/10.1097/QAI.0000000000002429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495978/
https://www.ncbi.nlm.nih.gov/pubmed/32925387
http://dx.doi.org/10.1097/QAI.0000000000002429

Ejemplares similares